Genesco reported better-than-expected Q2 fiscal 2027 results, with a narrower adjusted loss and sales topping consensus, primarily driven by strong performance from its Journeys brand. The company maintained its full-year adjusted EPS guidance at the high end while lowering its sales outlook, indicating a focus on profitability over top-line growth.
Genesco's Q2 fiscal 2027 results showed a significant improvement, with an adjusted loss of 83 cents per share, much narrower than the $1.37 consensus and the prior year. This beat, coupled with sales exceeding expectations, signals a positive shift in the company's 'Footwear First' strategy, particularly driven by the strong performance of Journeys and Johnston & Murphy. While the overall sales outlook was slightly lowered, the company maintained its adjusted EPS guidance at the high end, suggesting a focus on margin expansion and cost management, which is a positive long-term indicator for profitability. The receipt of $22.5 million in tariff refunds and an expected $40-$50 million in cost savings through fiscal 2029 further bolster the financial outlook. For traders, the immediate positive stock reaction (up 3% premarket) indicates market approval of the turnaround efforts, with the improved profitability and strong brand performance offering a short-term opportunity, while the long-term implications hinge on sustained execution of the strategy and easing of temporary sales pressures.